You just read:

MabVax Therapeutics Schedules Previously Announced 1-for-3 Reverse Stock Split to Regain Compliance with NASDAQ's $1.00 Minimum Bid Price Maintenance Requirement

News provided by

MabVax Therapeutics Holdings, Inc.

Feb 15, 2018, 07:30 ET